Specialty Business Services
Compare Stocks
4 / 10Stock Comparison
CTAS vs ROL vs ARMK vs ABM
Revenue, margins, valuation, and 5-year total return — side by side.
Personal Products & Services
Specialty Business Services
Specialty Business Services
CTAS vs ROL vs ARMK vs ABM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Specialty Business Services | Personal Products & Services | Specialty Business Services | Specialty Business Services |
| Market Cap | $67.28B | $25.95B | $11.85B | $2.36B |
| Revenue (TTM) | $10.79B | $3.84B | $18.79B | $8.87B |
| Net Income (TTM) | $1.90B | $529M | $317M | $158M |
| Gross Margin | 50.2% | 51.8% | 7.0% | 11.5% |
| Operating Margin | 23.0% | 19.0% | 4.2% | 3.7% |
| Forward P/E | 34.1x | 44.2x | 20.3x | 10.2x |
| Total Debt | $2.65B | $1.33B | $5.72B | $1.69B |
| Cash & Equiv. | $264M | $100M | $639M | $104M |
CTAS vs ROL vs ARMK vs ABM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Cintas Corporation (CTAS) | 100 | 269.3 | +169.3% |
| Rollins, Inc. (ROL) | 100 | 193.1 | +93.1% |
| Aramark (ARMK) | 100 | 241.2 | +141.2% |
| ABM Industries Inco… (ABM) | 100 | 130.8 | +30.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CTAS vs ROL vs ARMK vs ABM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CTAS has the current edge in this matchup, primarily because of its strength in long-term compounding and sleep-well-at-night.
- 6.7% 10Y total return vs ROL's 378.0%
- Lower volatility, beta 0.51, Low D/E 56.7%, current ratio 2.09x
- 17.6% margin vs ARMK's 1.7%
- 18.7% ROA vs ARMK's 2.4%, ROIC 25.8% vs 7.3%
ROL is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 11.0%, EPS growth 13.5%, 3Y rev CAGR 11.7%
- 11.0% revenue growth vs ABM's 4.6%
- Beta 0.23 vs ARMK's 0.78, lower leverage
ARMK is the clearest fit if your priority is momentum.
- +18.6% vs CTAS's -21.5%
ABM is the clearest fit if your priority is income & stability and valuation efficiency.
- Dividend streak 36 yrs, beta 0.71, yield 2.6%
- PEG 0.04 vs ROL's 2.93
- Beta 0.71, yield 2.6%, current ratio 1.48x
- Lower P/E (10.2x vs 20.3x)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 11.0% revenue growth vs ABM's 4.6% | |
| Value | Lower P/E (10.2x vs 20.3x) | |
| Quality / Margins | 17.6% margin vs ARMK's 1.7% | |
| Stability / Safety | Beta 0.23 vs ARMK's 0.78, lower leverage | |
| Dividends | 2.6% yield, 36-year raise streak, vs CTAS's 0.9% | |
| Momentum (1Y) | +18.6% vs CTAS's -21.5% | |
| Efficiency (ROA) | 18.7% ROA vs ARMK's 2.4%, ROIC 25.8% vs 7.3% |
CTAS vs ROL vs ARMK vs ABM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CTAS vs ROL vs ARMK vs ABM — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CTAS leads in 2 of 6 categories
ABM leads 2 • ARMK leads 1 • ROL leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CTAS leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ARMK is the larger business by revenue, generating $18.8B annually — 4.9x ROL's $3.8B. CTAS is the more profitable business, keeping 17.6% of every revenue dollar as net income compared to ARMK's 1.7%. On growth, ROL holds the edge at +10.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $10.8B | $3.8B | $18.8B | $8.9B |
| EBITDAEarnings before interest/tax | $2.9B | $858M | $1.3B | $431M |
| Net IncomeAfter-tax profit | $1.9B | $529M | $317M | $158M |
| Free Cash FlowCash after capex | $1.8B | $621M | $257M | $327M |
| Gross MarginGross profit ÷ Revenue | +50.2% | +51.8% | +7.0% | +11.5% |
| Operating MarginEBIT ÷ Revenue | +23.0% | +19.0% | +4.2% | +3.7% |
| Net MarginNet income ÷ Revenue | +17.6% | +13.8% | +1.7% | +1.8% |
| FCF MarginFCF ÷ Revenue | +16.5% | +16.2% | +1.4% | +3.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +9.3% | +10.2% | +6.1% | +6.1% |
| EPS Growth (YoY)Latest quarter vs prior year | +11.0% | 0.0% | -7.7% | -7.2% |
Valuation Metrics
ABM leads this category, winning 7 of 7 comparable metrics.
Valuation Metrics
At 15.5x trailing earnings, ABM trades at a 69% valuation discount to ROL's 49.4x P/E. Adjusting for growth (PEG ratio), ABM offers better value at 0.05x vs ROL's 3.27x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $67.3B | $25.9B | $11.8B | $2.4B |
| Enterprise ValueMkt cap + debt − cash | $69.7B | $27.2B | $16.9B | $3.9B |
| Trailing P/EPrice ÷ TTM EPS | 37.95x | 49.39x | 36.95x | 15.52x |
| Forward P/EPrice ÷ next-FY EPS est. | 34.12x | 44.18x | 20.27x | 10.15x |
| PEG RatioP/E ÷ EPS growth rate | 2.27x | 3.27x | — | 0.05x |
| EV / EBITDAEnterprise value multiple | 24.41x | 31.82x | 13.35x | 9.16x |
| Price / SalesMarket cap ÷ Revenue | 6.51x | 6.90x | 0.64x | 0.27x |
| Price / BookPrice ÷ Book value/share | 14.62x | 18.96x | 3.81x | 1.41x |
| Price / FCFMarket cap ÷ FCF | 38.29x | 39.91x | 26.07x | 15.19x |
Profitability & Efficiency
CTAS leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
CTAS delivers a 42.6% return on equity — every $100 of shareholder capital generates $43 in annual profit, vs $9 for ABM. CTAS carries lower financial leverage with a 0.57x debt-to-equity ratio, signaling a more conservative balance sheet compared to ARMK's 1.81x. On the Piotroski fundamental quality scale (0–9), CTAS scores 9/9 vs ROL's 5/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +42.6% | +36.9% | +9.8% | +8.8% |
| ROA (TTM)Return on assets | +18.7% | +16.7% | +2.4% | +3.0% |
| ROICReturn on invested capital | +25.8% | +23.5% | +7.3% | +7.5% |
| ROCEReturn on capital employed | +29.8% | +32.2% | +8.7% | +8.2% |
| Piotroski ScoreFundamental quality 0–9 | 9 | 5 | 7 | 6 |
| Debt / EquityFinancial leverage | 0.57x | 0.97x | 1.81x | 0.95x |
| Net DebtTotal debt minus cash | $2.4B | $1.2B | $5.1B | $1.6B |
| Cash & Equiv.Liquid assets | $264M | $100M | $639M | $104M |
| Total DebtShort + long-term debt | $2.7B | $1.3B | $5.7B | $1.7B |
| Interest CoverageEBIT ÷ Interest expense | 24.61x | 23.14x | 2.20x | 3.25x |
Total Returns (Dividends Reinvested)
ARMK leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CTAS five years ago would be worth $19,239 today (with dividends reinvested), compared to $8,552 for ABM. Over the past 12 months, ARMK leads with a +18.6% total return vs CTAS's -21.5%. The 3-year compound annual growth rate (CAGR) favors ARMK at 23.3% vs ABM's 0.7% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -9.4% | -8.5% | +23.6% | -4.5% |
| 1-Year ReturnPast 12 months | -21.5% | -3.8% | +18.6% | -18.6% |
| 3-Year ReturnCumulative with dividends | +49.1% | +33.7% | +87.5% | +2.0% |
| 5-Year ReturnCumulative with dividends | +92.4% | +51.9% | +72.7% | -14.5% |
| 10-Year ReturnCumulative with dividends | +671.6% | +378.0% | +97.2% | +47.0% |
| CAGR (3Y)Annualised 3-year return | +14.2% | +10.2% | +23.3% | +0.7% |
Risk & Volatility
Evenly matched — ROL and ARMK each lead in 1 of 2 comparable metrics.
Risk & Volatility
ROL is the less volatile stock with a 0.23 beta — it tends to amplify market swings less than ARMK's 0.78 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ARMK currently trades 96.2% from its 52-week high vs CTAS's 72.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.51x | 0.23x | 0.78x | 0.71x |
| 52-Week HighHighest price in past year | $229.24 | $66.14 | $46.88 | $52.94 |
| 52-Week LowLowest price in past year | $165.46 | $52.34 | $35.07 | $36.96 |
| % of 52W HighCurrent price vs 52-week peak | +72.8% | +81.4% | +96.2% | +75.9% |
| RSI (14)Momentum oscillator 0–100 | 39.5 | 44.5 | 56.1 | 55.8 |
| Avg Volume (50D)Average daily shares traded | 2.1M | 2.6M | 2.2M | 513K |
Analyst Outlook
ABM leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CTAS as "Hold", ROL as "Hold", ARMK as "Buy", ABM as "Hold". Consensus price targets imply 33.8% upside for CTAS (target: $223) vs 4.7% for ARMK (target: $47). For income investors, ABM offers the higher dividend yield at 2.60% vs CTAS's 0.89%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Buy | Hold |
| Price TargetConsensus 12-month target | $223.40 | $63.75 | $47.20 | $50.00 |
| # AnalystsCovering analysts | 30 | 17 | 24 | 11 |
| Dividend YieldAnnual dividend ÷ price | +0.9% | +1.3% | +0.9% | +2.6% |
| Dividend StreakConsecutive years of raises | 3 | 23 | 1 | 36 |
| Dividend / ShareAnnual DPS | $1.49 | $0.68 | $0.41 | $1.05 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.4% | +0.8% | +1.2% | +5.2% |
CTAS leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ABM leads in 2 (Valuation Metrics, Analyst Outlook). 1 tied.
CTAS vs ROL vs ARMK vs ABM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CTAS or ROL or ARMK or ABM a better buy right now?
For growth investors, Rollins, Inc.
(ROL) is the stronger pick with 11. 0% revenue growth year-over-year, versus 4. 6% for ABM Industries Incorporated (ABM). ABM Industries Incorporated (ABM) offers the better valuation at 15. 5x trailing P/E (10. 2x forward), making it the more compelling value choice. Analysts rate Aramark (ARMK) a "Buy" — based on 24 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CTAS or ROL or ARMK or ABM?
On trailing P/E, ABM Industries Incorporated (ABM) is the cheapest at 15.
5x versus Rollins, Inc. at 49. 4x. On forward P/E, ABM Industries Incorporated is actually cheaper at 10. 2x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: ABM Industries Incorporated wins at 0. 04x versus Rollins, Inc. 's 2. 93x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — CTAS or ROL or ARMK or ABM?
Over the past 5 years, Cintas Corporation (CTAS) delivered a total return of +92.
4%, compared to -14. 5% for ABM Industries Incorporated (ABM). Over 10 years, the gap is even starker: CTAS returned +671. 6% versus ABM's +47. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CTAS or ROL or ARMK or ABM?
By beta (market sensitivity over 5 years), Rollins, Inc.
(ROL) is the lower-risk stock at 0. 23β versus Aramark's 0. 78β — meaning ARMK is approximately 236% more volatile than ROL relative to the S&P 500. On balance sheet safety, Cintas Corporation (CTAS) carries a lower debt/equity ratio of 57% versus 181% for Aramark — giving it more financial flexibility in a downturn.
05Which is growing faster — CTAS or ROL or ARMK or ABM?
By revenue growth (latest reported year), Rollins, Inc.
(ROL) is pulling ahead at 11. 0% versus 4. 6% for ABM Industries Incorporated (ABM). On earnings-per-share growth, the picture is similar: ABM Industries Incorporated grew EPS 102. 3% year-over-year, compared to 13. 5% for Rollins, Inc.. Over a 3-year CAGR, ROL leads at 11. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CTAS or ROL or ARMK or ABM?
Cintas Corporation (CTAS) is the more profitable company, earning 17.
5% net margin versus 1. 8% for Aramark — meaning it keeps 17. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CTAS leads at 22. 8% versus 3. 7% for ABM. At the gross margin level — before operating expenses — CTAS leads at 50. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CTAS or ROL or ARMK or ABM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, ABM Industries Incorporated (ABM) is the more undervalued stock at a PEG of 0. 04x versus Rollins, Inc. 's 2. 93x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, ABM Industries Incorporated (ABM) trades at 10. 2x forward P/E versus 44. 2x for Rollins, Inc. — 34. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CTAS: 33. 8% to $223. 40.
08Which pays a better dividend — CTAS or ROL or ARMK or ABM?
All stocks in this comparison pay dividends.
ABM Industries Incorporated (ABM) offers the highest yield at 2. 6%, versus 0. 9% for Cintas Corporation (CTAS).
09Is CTAS or ROL or ARMK or ABM better for a retirement portfolio?
For long-horizon retirement investors, Rollins, Inc.
(ROL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 23), 1. 3% yield, +378. 0% 10Y return). Both have compounded well over 10 years (ROL: +378. 0%, ARMK: +97. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CTAS and ROL and ARMK and ABM?
These companies operate in different sectors (CTAS (Industrials) and ROL (Consumer Cyclical) and ARMK (Industrials) and ABM (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CTAS is a mid-cap quality compounder stock; ROL is a mid-cap quality compounder stock; ARMK is a mid-cap quality compounder stock; ABM is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.